Skip to main content

Table 1 Background characteristics for all women recruited into the study (n = 748)

From: The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial

  Misoprostol Placebo
Number of women 374 374
Site of recruitment (n, %):
Mbale Regional Referral Hospital 157 (42.0) 153 (40.9)
Busiu (level IV health centre) 119 (31.8) 119 (31.8)
Lwangoli (level III health centre) 56 (15.0) 54 (14.4)
Siira (level III health centre) 42 (11.2) 48 (12.8)
Age (mean, SD) 26.4 (6.2) 26.2 (6.4)
Primary occupation (n, %):
Housewife 277 (74.1) 284 (75.9)
Employed 85 (22.7) 80 (21.4)
Unemployed / student fc12 ( 3.2) 10 ( 2.7)
Highest level of education completed (n, %):
No education 24 ( 6.4) 27 ( 7.2)
Primary 202 (54.2) 197 (52.7)
Secondary or higher 147 (39.3) 150 (40.1)
Estimated gestational age (mean, SD) 35.3 (1.4) 35.3 (1.5)
Nulliparous (n, %) 81 (21.7) 83 (22.2)
Previous CS deliveries (n, %)
0 365 (97.6) 367 (98.1)
1 7 ( 1.9) 7 ( 1.9)
2 2 ( 0.5) 0
Haemoglobin (mean g/dl, SD, range)) 11.2 (1.4) [6.9 – 14.7] 11.2 (1.4) [5.8 – 14.8]
Normal 207 (55.3 %) 214 (57.2 %)
Mild anaemia 136 (36.4 %) 127 (34.0 %)
Moderate anaemia 27 ( 7.2 %) 31 ( 8.3 %)
Severe anaemia* 3 ( 0.8 %) 2 ( 0.5 %)
  1. † : not recorded for 1 participant in misoprostol group
  2. ‡: the number of previous CS was not recorded for one participant and a single CS was assumed
  3. * : anaemia shown by WHO classification: normal (>11 g/dl), mild (9–10.99 g/dl), moderate (7–8.99 g/dl) and severe (<7 g/dl). Data is missing for one participant in the misoprostol arm